Please assess the completion status of the following clinical trial:

Trial Title: Somatosensory Profiling in Radicular Pain Patients And it's Correlation With Treatment Outcome

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* diagnosis of lower extremity radicular pain regardless of specific or suspected etiologies~* scheduling an epidural steroid injection (ESI)~Exclusion Criteria:~* a major psychiatric disorder requiring a recent (within one month) hospitalization, such as major depression, bipolar disorder, schizophrenia, anxiety disorder, and psychosis~* subject is taking illicit or recreational drug detected through a urine toxicology screen~* subject has had an interventional pain management procedures within the last eight weeks that may alter QST responses including neuraxial or local anesthetic block~* subject had a change in dosage of neuromodulatory pain medication (including gabapentin, pregabalin, cymbalta, amitriptyline, nortriptyline, trileptal, etc) in the past two weeks~* subject is pregnant~* subject has pending litigation involving the current pain condition being treated and studied.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- >30% Pain Relief (Type: OTHER): All subjects have radicular pain and are scheduled to receive an epidural steroid injection (ESI) as a treatment. The ESI treatment is conducted by the subject's clinical physician and is not given as part of the research study procedures. Quantitative Sensory Testing (QST) will be conducted before and after the ESI treatment. QST consists of hot and cold temperature testing using the QST device. This group of subjects received greater than 30% pain relief.
- <30% Pain Relief (Type: OTHER): All subjects have radicular pain and are scheduled to receive an epidural steroid injection (ESI) as a treatment. The ESI treatment is conducted by the subject's clinical physician and is not given as part of the research study procedures. Quantitative Sensory Testing (QST) will be conducted before and after the ESI treatment. QST consists of hot and cold temperature testing using the QST device. This group of subjects received less than 30% pain relief.

Based on this trial design, predict the completion outcome and termination type (if applicable).